Clinical Trial Update: Effects of Flaxseed Supplementation in Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating flaxseed supplementation for metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Flaxseed supplement (Linum usitatissimum seed supplement)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED